Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 174 of the 174 references it cites were found in a registry or an index; 115 of the 206 sources its claims cite were checked for support.

Neuroplasticity in cognitive and psychological mechanisms of depression: an integrative model

Open access
Price, Rebecca B., Duman, Ronald · 2020 · Molecular Psychiatry

Abstract

Chronic stress and depressive-like behaviors in basic neuroscience research have been associated with impairments of neuroplasticity, such as neuronal atrophy and synaptic loss in the medial prefrontal cortex (mPFC) and hippocampus. The current review presents a novel integrative model of neuroplasticity as a multi-domain neurobiological, cognitive, and psychological construct relevant in depression and other related disorders of negative affect (e.g., anxiety). We delineate a working conceptual model in which synaptic plasticity deficits described in animal models are integrated and conceptually linked with human patient findings from cognitive science and clinical psychology. We review relevant reports including neuroimaging findings (e.g., decreased functional connectivity in prefrontal-limbic circuits), cognitive deficits (e.g., executive function and memory impairments), affective information processing patterns (e.g., rigid, negative biases in attention, memory, interpretations, and self-associations), and patient-reported symptoms (perseverative, inflexible thought patterns; inflexible and maladaptive behaviors). Finally, we incorporate discussion of integrative research methods capable of building additional direct empirical support, including using rapid-acting treatments (e.g., ketamine) as a means to test this integrative model by attempting to simultaneously reverse these deficits across levels of analysis.

Overview

CoChat Summary

TL;DR

This integrative review proposes neuroplasticity as a multi-domain construct linking molecular/cellular synaptic deficits in depression to neural network, cognitive, affective information processing, and clinical/self-report levels. It argues that rapid-acting treatments such as ketamine can test the model by simultaneously reversing deficits across these levels.

Key findings

  • Depression is associated with robust decreases in hippocampal and PFC volumes; large imaging corpuses including >1000 unipolar depressed patients and many thousands of healthy controls documented particularly robust hippocampal volume decreases, driven by recurrent depression and early age of onset (≤age 21). Amygdalar volume decreases were seen only in early-onset depression and were not statistically robust after multiple-comparison correction; robust cortical thickness decreases were observed in medial and orbital PFC and anterior cingulate cortex.
  • Meta-analytic executive-function findings in depressed patients show pronounced deficits (Cohen’s d ≥1.0) in cognitive flexibility, inhibition capacity, and verbal fluency, plus moderate impairments in strategic planning and organization; attention and concentration are also broadly impaired.
  • Ketamine shows well-replicated rapid antidepressant effects in randomized controlled trials (meta-analytic Cohen’s d=1.4), attributed to rapid reversal of neuroplasticity deficits; a single dose increases BDNF release, stimulates mTORC1 signaling, increases synaptic proteins (GluR1, PSD95, synapsin 1), and increases synapse number and function in PFC, with new synapse formation causally related to antidepressant-like actions.
  • The proposed model predicts that an agent reversing molecular neuroplasticity deficits should produce correlated, simultaneous reversals across neural network, cognitive, affective information processing, and self-report levels; ketamine findings are presented as preliminary support, including increased PFC connectivity, improved cognitive flexibility, and rapid shifts in implicit self-representations.

Methods

  • Narrative/integrative review, not a primary empirical study; it synthesizes findings from basic neuroscience animal models, human neuroimaging, cognitive science, and clinical psychology.
  • The paper delineates a working conceptual model across molecular/cellular, neural network, cognitive function, affective information processing, and clinical/self-report levels (Table 1; Figure 1).
  • It uses intravenous ketamine as a test case for the model’s falsifiable prediction of simultaneous, correlated reversals across levels of analysis, and discusses experimental manipulation at each level (Table 2).

Limitations

  • The paper states that direct empirical links across levels remain quite preliminary (Table 2), and that further integration across multiple markers is needed.
  • It notes marked heterogeneity of depressed patients at neural network, cognitive, information processing, and clinical levels, and that no known intervention strategy is effective for all depressed patients.
  • It states that ketamine research has focused largely on molecular effects in animal models or symptom-level effects in human patients, that molecular endpoints are difficult to assess in the living brain, and that larger sample sizes are likely needed for individual-differences and mediational investigations. Evident from the text: as a narrative review, it does not report a systematic search strategy or quantitative synthesis.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1038/s41380-019-0615-x

Cites

174 of 174 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

66 Valid · 20 Not valid · 33 Not checked · 19 Own results and interpretations

66 more claims · 36 with their cited sources checked

Create a free account to see all 138 claims and to verify the 1 reference still open.

See all claims — free account
  • It may state two separate claims as one. 51
  • Probably not a substantial claim. 29

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 171 references

Research works printed but not linked: 1

  1. Fuster JM. The prefrontal cortex. 3rd edn. Philadelphia, PA: Lippincott-Raven; 1997.

Cited by

See all 739

Metadata

Authors
Price, R. B., & Duman, R.
Affiliations
  • University of Pittsburgh (US)
  • Yale University (US)
Corresponding author
Price, Rebecca B.
Venue
Molecular Psychiatry
Published
2019-12-04
Volume
25
Issue
3
Pages
530-543
ISSN
  • 1359-4184 (ISSN-L)
  • 1476-5578
OpenAlex
W2994049374
Cited by
739
References
171
Citations by year
2026: 121 · 2025: 170 · 2024: 158 · 2023: 127 · 2022: 82 · 2021: 60 · 2020: 21
FWCI
4.58
Type
journal article
Language
en
Open access
Licence
Locations
  • Molecular Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (R01MH113857)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
Keywords
neuroplasticity, depression, chronic stress, synaptic plasticity, medial prefrontal cortex, hippocampus, negative affect, anxiety, executive function, memory impairment, attentional bias, cognitive biases, ketamine, rapid-acting antidepressants, integrative model
MeSH terms
Animals, Brain, Cognition, Cognition Disorders, Depression, Depressive Disorder, Hippocampus, Humans, Memory, Nerve Net, Neuronal Plasticity, Neurons, Stress, Psychological, Prefrontal Cortex, Cognitive Dysfunction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-02, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-02 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Neuroplasticity in cognitive and psychological mechanisms of depression: an integrative model. https://app.cochat.ai/papers/10.1038/s41380-019-0615-x
The paper
Price, R. B., & Duman, R. (2020). Neuroplasticity in cognitive and psychological mechanisms of depression: an integrative model. Molecular Psychiatry. https://doi.org/10.1038/s41380-019-0615-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.